Quadrature Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Quadrature Capital's VRTX Position: Q2 2026 in Review
Quadrature Capital opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 46,945 shares worth $23.3M. The stake represents 0.2% of the portfolio and ranks #102 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in VRTX as recently as Q4 2025.
Quadrature Capital first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $58.7M in Q3 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Quadrature Capital held 46,945 shares of Vertex Pharmaceuticals worth $23.3M as of Q2 2026.
- Vertex Pharmaceuticals was a new Quadrature Capital position in Q2 2026.
- Vertex Pharmaceuticals made up 0.2% of Quadrature Capital's portfolio in Q2 2026, its #102 holding.
- Quadrature Capital first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- Quadrature Capital's Vertex Pharmaceuticals position peaked at $58.7M in Q3 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.